Craig A Collard's Net Worth
$36 Million
Who is Craig A Collard?
Craig A Collard has an estimated net worth of $36 Million. This is based on reported shares across multiple companies, which include TerrAscend Corp., Sierra Oncology, Inc., OPIANT PHARMACEUTICALS, INC., HERON THERAPEUTICS, INC. /DE/, CORNERSTONE THERAPEUTICS INC, and MULTI LINK TELECOMMUNICATIONS INC.
SEC CIK
Craig A Collard's CIK is 0001363558
Past Insider Trading and Trends
2022 was Craig A Collard's most active year for acquiring shares with 11 total transactions. Craig A Collard's most active month to acquire stocks was the month of May. 2014 was Craig A Collard's most active year for disposing of shares, totalling 9 transactions. Craig A Collard's most active month to dispose stocks was the month of January. 2022 saw Craig A Collard paying a total of $604,040.15 for 438,831 shares, this is the most they've acquired in one year. In 2014 Craig A Collard cashed out on 2,337,924 shares for a total of $19,193,925.57, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TerrAscend Corp. (TSNDF) Snapshot price: $2.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +31.52% | 132.65K |
—
|
—
| 553.51K |
Jun 22
| |||
Form 4
| +16.63% | 60K |
—
|
—
| 420.87K |
Sep 23
| |||
Form 4
| +49.82% | 120K |
—
|
—
| 360.87K |
Sep 22
| |||
Form 4
| +90.48% | 114.41K |
—
|
—
| 240.87K |
Jun 27
| |||
Form 4
| +72.01% | 52.94K |
$2.54 | $134,465.06 | 126.45K |
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sierra Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.50K |
$55.00 | -$742,500.00 |
0
|
Jul 1
| |||
Form 4
|
∞
| 13.5K |
$23.03 | $310,863.36 | 13.5K |
Nov 23 - Nov 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OPIANT PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -55.82K |
$20.00 | -$1,116,440.00 |
0
|
Mar 2
| |||
Form 4
| +3.72% | 2K |
—
|
—
| 55.82K |
Jun 14
| |||
Form 4
| +11.84% | 5.7K |
$11.10 | $63,266.48 | 53.82K |
Jun 10 - Jun 13
| |||
Form 4
| +129.46% | 27.15K |
$13.54 | $367,611.00 | 48.12K |
May 16
| |||
Form 4
| +21.34% | 3.69K |
$10.49 | $38,697.61 | 20.97K |
May 13
| |||
Form 4
| +27.30% | 3.71K |
$18.10 | $67,061.76 | 17.28K |
Sep 13
| |||
Form 4
| +239.43% | 9.58K |
$18.18 | $174,109.86 | 13.58K |
Sep 10
| |||
Form 4
| +100.00% | 2K |
—
|
—
| 4K |
Jun 15
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HERON THERAPEUTICS, INC. /DE/ (HRTX) Snapshot price: $2.26
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.54% | 13.8K |
—
|
—
| 262.79K |
Jan 19 - Apr 19
| |||
Form 4
| +33.51% | 62.5K |
—
|
—
| 249K |
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
| +411.00% | 150K |
$0.92 | $137,970.00 | 186.5K |
Nov 16
| |||
Form 4
| -1.86% | -692.00 |
$1.65 | -$1,141.80 | 36.5K |
Aug 22
| |||
Form 4
| -1.82% | -691.00 |
$1.45 | -$1,001.95 | 37.19K |
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CORNERSTONE THERAPEUTICS INC No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.61M |
$9.50 | -$15,316,137.50 |
0
|
Feb 3
| |||
Form 4
| +2.87% | 45K |
—
|
—
| 1.61M |
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 29
| |||
Form 4
| -100.00% | -1.44M |
$6.25 | -$9,024,456.25 |
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
| -11.34% | -385.00K |
$6.02 | -$2,317,700.00 | 3.01M |
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
| -26.90% | -1.25M |
$5.50 | -$6,875,000.00 | 3.4M |
Jul 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
| +145.09% | 4.65M |
—
|
—
| 7.85M |
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||